Grants for Special district governments - Health

This funding opportunity provides financial support for government agencies, non-profits, and tribal entities in Arizona to deliver evidence-based home visiting services to low-income pregnant individuals and their families, aiming to improve maternal and infant health outcomes.

The purpose of this notice of funding opportunity (NOFO) is to invite applications for Research Centers (RC) to support the Centers for Research in Emerging Infectious Diseases (CREID) Network. The CREID network serves to expand knowledge on re-emerging and emerging infectious diseases (re/EIDs) around the globe where outbreaks are most likely to occur. Multi- and inter-disciplinary teams of domestic and international investigators will conduct innovative, collaborative One Health (approach that recognizes the health of humans is interconnected with that of animal health and the shared environment) based research projects and will mount a rapid and effective research response to outbreaks through coordination, collaboration, and cooperation across the CREID Network.

This funding opportunity provides financial support for researchers and organizations to develop and validate innovative technologies that improve the understanding and treatment of cancer, with a focus on addressing unmet needs and health disparities.

This funding opportunity provides financial support to various organizations and governments to develop and implement trauma-informed services for children affected by violence in their homes, schools, and communities.

This funding opportunity supports U.S. colleges and universities in developing programs that enhance diversity and provide research training for undergraduate students from underrepresented groups, preparing them for advanced biomedical research careers.

This funding opportunity provides financial support for research projects aimed at improving antibiotic use and reducing antibiotic resistance in healthcare settings, particularly in long-term care and outpatient environments.

USAID/DRCs vision for Kitumaini is a five-year long activity that will focus on service deliveryresults in five (5) health zones in Haut-Katanga, with possible expansion to other provinces asguided by Office of the Global AIDS Coordinator (OGAC)/PEPFAR. This activity also intends tostrengthen the capacity of local sub-recipients to enhance their capabilities to receive assistanceawards from USAID through transition award(s). This service delivery and capacity buildingactivity will include all aspects of HIV epidemic control. Activities will take place in health zonesassigned to USAID/DRC. This service delivery activity will prioritize services that focus on prioritypopulations, orphans and vulnerable children (OVC) and key populations (KP). The recipient willcoordinate with other implementing partners to facilitate the transition of the existing KPprogram, Meeting Targets and Maintaining Epidemic Control (EpiC) to Kitumaini.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

This funding opportunity supports innovative research on how environmental toxicants impact RNA modifications and their role in health issues, targeting universities, nonprofits, and for-profit organizations involved in related studies.

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) is a funding opportunity designed to support early-stage physicians and health professionals who are committed to aging and aging-related diseases research, helping them to enhance their research and leadership skills, establish independent research programs, and prepare to lead in their field to improve health outcomes for older individuals.

This funding opportunity provides financial support to organizations working in Botswana to strengthen laboratory and health systems for effective management of HIV and TB programs.

This grant provides funding for researchers and institutions to develop advanced tissue-engineered models that better mimic cancer biology, aiming to improve understanding and treatment of various cancer types.

This funding opportunity is designed to support a centralized leadership and coordination center that will oversee a comprehensive study on the health of adults living with HIV and similar individuals, focusing on improving health outcomes and addressing disparities through community engagement and scientific research.

This funding opportunity supports large-scale research projects aimed at combating antibiotic-resistant infections in various healthcare settings, targeting institutions and organizations dedicated to improving public health and patient safety.

This funding opportunity provides financial support to various organizations focused on improving maternal and child health services across the United States, including state programs, urban initiatives, and home visiting services.

This funding opportunity provides financial support to accredited organizations in Puerto Rico to enhance poison control services and improve public health responses to poisoning incidents.

This grant provides funding for researchers to develop innovative methods for improving cancer communication and prevention strategies in today's digital landscape, focusing on the impact of online information and health disparities.

This grant provides funding to organizations that engage with justice-involved individuals to conduct research aimed at preventing substance use disorders and overdose, enhancing community support and treatment access.

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

This funding opportunity provides support for research institutions to conduct early-phase clinical trials focused on cancer prevention interventions across various organ sites.